Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]
Bio2RDF identifier
NCT00002487
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002487
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... cisplatin-based chemotherapy.
brief title [clinicaltrials_vocabulary:brief-title]
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... patients/year is anticipated.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
recurrent ovarian epithelial cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-09-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002487
official title [clinicaltrials_vocabulary:official-title]
INTRAPERITONEAL METHOTREXATE A ...... FOR ADVANCED OVARIAN CARCINOMA
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000077374
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
CAN-OTT-9017
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1991-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2000-04-01T00:00:00Z
identifier
clinicaltrials:NCT00002487
title
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
@en
type
label
Methotrexate Plus Dipyridamole ...... r [clinicaltrials:NCT00002487]
@en